08.07.21
BMH BRÄUTIGAM advises DEC on the financing of the acquisition of Extract Technology
BMH BRÄUTIGAM advised the DEC Group on the financing of the acquisition of Extract Technology (UK / US).
The Dec Group, a portfolio company of the capiton V fund and leading provider worldwide of containment powder handling systems, has acquired the Extract Technology business from US-listed Wabash National Corporation, a company listed on the New York Stock Exchange. Extract Technology is a leading provider of containment and aseptic systems for the pharmaceutical, biotech, nuclear and chemical markets. Extract is headquartered in Huddersfield, UK, with an additional site in New Lisbon, USA, serving the fast-growing US market.
In this transaction, the DEC Group was advised by BMH BRÄUTIGAM with regard to the financing and the acquisition of further shares in group companies. For aspects of Swiss law, BMH BRÄUTIGAM called on MLL Meyerlustenberger Lachenal (lead Dr. Christoph Heiz) from its international network.
Background:
The team of BMH BRÄUTIGAM has been advising capiton for years, including the acquisition of the DEC Group. Other advisors to DEC: Shoosmiths (Legal UK / Transaction, led by Simon Procter), PwC (Financial), EY (Tax). Advisors to banks: Baker McKenzie (lead Dr. Philip Spoerlé, Zurich).
Team BMH BRÄUTIGAM:
Dr. Andrea Reichert-Clauss, David Thüning, Tina Schmidt, Till Wansleben (all Private Equity ǀ Corporate/M&A)
In this transaction, the DEC Group was advised by BMH BRÄUTIGAM with regard to the financing and the acquisition of further shares in group companies. For aspects of Swiss law, BMH BRÄUTIGAM called on MLL Meyerlustenberger Lachenal (lead Dr. Christoph Heiz) from its international network.
Background:
The team of BMH BRÄUTIGAM has been advising capiton for years, including the acquisition of the DEC Group. Other advisors to DEC: Shoosmiths (Legal UK / Transaction, led by Simon Procter), PwC (Financial), EY (Tax). Advisors to banks: Baker McKenzie (lead Dr. Philip Spoerlé, Zurich).
Team BMH BRÄUTIGAM:
Dr. Andrea Reichert-Clauss, David Thüning, Tina Schmidt, Till Wansleben (all Private Equity ǀ Corporate/M&A)